Commentary

Article

State of the Science Summit - Hematologic Malignancies: Chaired by Annie Im, MD, FASCO

State of the Science Summit - Hematologic Malignancies: Chaired by Annie Im, MD, FASCO

State of the Science Summit - Hematologic Malignancies: Chaired by Annie Im, MD, FASCO

Speakers

  • James Rossetti, DO | UPMC Hillman Cancer Center
  • Alison Rager Sehgal, MD | UPMC Hillman Cancer Center
  • Emily Geramita, MD, PhD | UPMC Hillman Cancer Center
  • Jing-Zhou Hou, MD, PhD | UPMC Hillman Cancer Center
  • Kathleen A. Dorritie, MD | UPMC Hillman Cancer Center

Topics

  • Have Standards Evolved in MF and PV?
  • How do you manage patients with myelodysplastic syndromes (MDS)
  • Case Presentation: MDS
  • Treatment of older AML
  • Year in Review: Updates in DLBCL
  • Upfront treatment of CLL

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Sujith Samarasinghe, MD
Comparative Efficacy of Bruton Tyrosine Kinase Inhibitors in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia: A Network Meta-Analysis
Michael R. Grunwald, MD, FACP
Shella Saint Fleur-Lominy, MD, PhD
Manali Kamdar, MD
Matthew Matasar, MD, chief, Division of Blood Disorders, Rutgers Cancer Institute; professor, medicine, Rutgers Robert Wood Johnson Medical School
Sattva S. Neelapu, MD
Julia Foldi, MD, PhD
Sattva S. Neelapu, MD
Julie M. Vose, MD, MBA